Imaging Colorectal Cancer with VIP Scintigraphy
Author Information
Author(s): M Raderer, A Kurtaran, M Hejnal, F Vorbeck, P Angelberger, W Schefthauer, I Virgolini
Primary Institution: University of Vienna
Hypothesis
Can vasoactive intestinal peptide receptor scintigraphy improve the visualization of colorectal adenocarcinomas?
Conclusion
VIP receptor scintigraphy is a sensitive method for imaging colorectal cancer and can provide valuable information beyond conventional imaging techniques.
Supporting Evidence
- 87% of primary cancers and 82% of locally relapsing cancers were successfully imaged with VIP.
- No false positive scans were obtained in patients who had undergone curative resection.
- VIP scans indicated disease presence before CT in four patients.
Takeaway
Doctors used a special scan to find cancer in people's colons, and it worked really well, helping them see things that regular scans might miss.
Methodology
Eighty patients with colorectal cancer underwent VIP receptor scintigraphy and their results were compared with conventional CT scans.
Limitations
The study did not evaluate the impact of chemotherapy on receptor expression, which could affect scan results.
Participant Demographics
36 women and 44 men with a median age of 67 years.
Want to read the original?
Access the complete publication on the publisher's website